Company Information

CIN
Status
Date of Incorporation
10 August 2010
State / ROC
Goa / ROC Goa
Last Balance Sheet
31 March 2022
Last Annual Meeting
30 September 2022
Paid Up Capital
270,000,000
Authorised Capital
270,000,000

Directors

Gajanan Jaivant Surlakar
Gajanan Jaivant Surlakar
Director/Designated Partner
over 2 years ago
Kashyap Keni
Kashyap Keni
Director/Designated Partner
over 2 years ago
Praveen Khullar
Praveen Khullar
Director/Designated Partner
over 3 years ago
Vini Prasad Keni
Vini Prasad Keni
Director
over 15 years ago

Past Directors

Amol Shivaji Borkar
Amol Shivaji Borkar
Additional Director
over 3 years ago
Prasad Vassudev Keni
Prasad Vassudev Keni
Director
over 15 years ago

Patents

Extended Release Oral Composition Of Metformin & Dpp4 Inhibitor

Provided are bilayer pharmaceutical compositions containing core matrix of release rate controlling polymer and metformin hydrochloride and immediate release layer composition of sitagliptin phosphate monohydrate.

Controlled Release Compositions Of Oxcarbazepine

Controlled release compositions of oxcarbazepine are disclosed using non cellulosic excipients as a rate controlling agents and sucrose as a binder with methacrylic acid copolymer and sodium lauryl sulfate as release promoting agents wherin enhancement in the dissolution is acheived by keeping drug and release promo...

Charges

28 Crore
18 August 2020
Axis Bank Limited
14 Crore
20 October 2021
Icici Bank Limited
10 Crore
20 October 2021
Icici Bank Limited
18 Crore
18 August 2020
Axis Bank Limited
0
20 October 2021
Others
0
20 October 2021
Others
0
18 August 2020
Axis Bank Limited
0
20 October 2021
Others
0
20 October 2021
Others
0

Documents

Form MGT-7-19122020_signed
Optional Attachment-(1)-18122020
Copy of MGT-8-18122020
List of share holders, debenture holders;-18122020
Optional Attachment-(1)-21112020
Statement of subsidiaries as per section 129-Form AOC-1 (To be attached in respect of Foreign subsidiaries)-21112020
XBRL document in respect Consolidated financial statement-21112020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-21112020
Form DIR-12-21112020_signed
Declaration by first director-21112020
Form AOC-4(XBRL)-21112020_signed
Form MSME FORM I-30102020_signed
Optional Attachment-(1)-14092020
Form CHG-1-14092020_signed
Instrument(s) of creation or modification of charge;-14092020
Optional Attachment-(2)-14092020
CERTIFICATE OF REGISTRATION OF CHARGE-20200914
Form DPT-3-21072020-signed
Optional Attachment-(1)-17072020
Form DIR-12-28052020_signed
Optional Attachment-(1)-28052020
Interest in other entities;-28052020
Declaration of the appointee director, Managing director, in Form No. DIR-2;-28052020
Copy of MGT-8-27122019
List of share holders, debenture holders;-27122019
Form MGT-7-27122019_signed
Form AOC-4(XBRL)-13112019_signed
Statement of subsidiaries as per section 129-Form AOC-1 (To be attached in respect of Foreign subsidiaries)-12112019
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-12112019
XBRL document in respect Consolidated financial statement-12112019